MedTrace Logo

Dexamethasone and Functional Outcome After TKA

NCT05137080 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 162

Last updated 2022-10-06

No results posted yet for this study

Summary

Patients previously included in the DEX-2-TKA-trial (ethics committee ID SJ-695; ClinicalTrials.gov: NCT03506789) at Næstved Hospital will be invited for a follow up study consisting of questionnaires and a visit with a physical therapist. The study includes the following validated questionnaires: EQ-5D-5L, Oxford Knee Score and PainDetect, and information on height, weight, daily pain-medication and co-morbidities. With the physical therapist, the patient will perform the following functional tests: knee range of motion, timed-up-to-go, 30 second chair stand test, 40m fast paced walk test, stair climb test and a measure of the thigh force.

Conditions

Interventions

DRUG

Dexamethasone

24mg dexamethasone

DRUG

Isotonic saline

Isotonic saline

Sponsors & Collaborators

  • Slagelse Hospital

    lead OTHER

Principal Investigators

  • Asger K Mølgaard, MD · Research Center for Anaesthesiology and Intensive Care Medicine, Department of Anaesthesiology, Næstved, Slagelse and Ringsted Hospitals

  • Daniel Hägi-Pedersen, MD, Ph.D. · Research Center for Anaesthesiology and Intensive Care Medicine, Department of Anaesthesiology, Næstved, Slagelse and Ringsted Hospitals

  • Kasper S Gasbjerg, MD · Research Center for Anaesthesiology and Intensive Care Medicine, Department of Anaesthesiology, Næstved, Slagelse and Ringsted Hospitals

  • Ole Mathiesen, MD, PhD, Assoc Prof · Centre for Anaesthesiological Research, Department of Anaesthesiology, Zealand University Hospital

  • Søren T Skou, PhD, Assoc Prof · PROgrez, Department of physical therapy and Occupational Therapy, Næstved, Slagelse and Ringsted Hospitals

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-15
Primary Completion
2022-06-07
Completion
2022-06-08

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05137080 on ClinicalTrials.gov